A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis.

Overall, enrollment of subjects proved feasible, and results from this pilot study, while inadequate for confirmation of the potential efficacy of CTX, provide evidence of study feasibility for future, more definitive clinical trials.